(Q45332996)

English

Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office

scientific article published in October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Pyllis C Tien

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Veterans Affairs Hepatitis C Resource Center Program

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

National Hepatitis C Program Office

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

2338-2354

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

The natural history of chronic hepatitis C in haemophiliacs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Hepatitis C and progression of HIV disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Therapy of acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Predictors of response to therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Fatal lactic acidosis in a HIV-positive patient treated with interferon and ribavirin for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Survival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00222.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2005.00222.X

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45332996&oldid=2075044924"